The chief pharmacist at the Ministry of Health and Wellness (MOHW) has praised the Caribbean Regulatory System (CRS), a regional mechanism for the assessment and monitoring of medicines, vaccines, and in vitro diagnostics, noting that The Bahamas continues to benefit from it after the passage of the COVID-19 pandemic.
Explaining the value of the CRS to The Bahamas, Dr. Gina A. Archer, in a press statement released by the Caribbean Public Health Agency (CARPHA) said: “The CRS was extremely important and instrumental to us during the COVID-19 pandemic, particularly in guiding the selection of safe, efficacious, and quality-assured vaccines from numerous donors and potential suppliers. The product recommendations helped us navigate a complex global landscape and ensured we only accepted vaccines from trusted sources, ultimately protecting public health”.
